Pharmaceutical Gallium Compositions and Methods
    7.
    发明申请
    Pharmaceutical Gallium Compositions and Methods 审中-公开
    药物组合物和方法

    公开(公告)号:US20090275654A1

    公开(公告)日:2009-11-05

    申请号:US12431026

    申请日:2009-04-28

    申请人: Bob D. Brown

    发明人: Bob D. Brown

    IPC分类号: A61K31/28 C07F5/00 A61P35/00

    CPC分类号: C07F5/003

    摘要: The present invention provides novel pharmaceutical gallium compositions, as well as methods for their preparation and methods for treating conditions and diseases such as cancer, hypercalcemia, osteoporosis, osteopenia, and Paget's disease.

    摘要翻译: 本发明提供了新颖的药物镓组合物,以及其制备方法以及治疗疾病如癌症,高钙血症,骨质疏松症,骨质减少症和佩吉特氏病的方法。

    Lipid delivery formulations
    8.
    发明授权
    Lipid delivery formulations 有权
    脂质递送配方

    公开(公告)号:US09320798B2

    公开(公告)日:2016-04-26

    申请号:US13595360

    申请日:2012-08-27

    申请人: Bob D. Brown

    发明人: Bob D. Brown

    摘要: The invention provides formulations that contain an immunogenic or immunostimulatory cargo, delivery moiety and/or lipid, and a lipid that functions to reduce or prevent induction in a subject of an immune response which would otherwise occur when the immunogenic or immunostimulatory cargo, delivery moiety and/or lipid is administered to a subject as a component of an appropriate control formulation lacking the immune response reducing lipid. Specific immune response reducing lipids and uses thereof are further provided.

    摘要翻译: 本发明提供含有免疫原性或免疫刺激性货物,递送部分和/或脂质的制剂,以及用于减少或预防免疫应答受试者诱导的脂质,否则当免疫原性或免疫刺激性货物,递送部分和 /或脂质作为缺乏免疫应答降低脂质的适当对照制剂的组分施用于受试者。 进一步提供减少脂质的特异性免疫应答及其用途。

    Oligonucleotides comprising a molecular switch
    9.
    发明授权
    Oligonucleotides comprising a molecular switch 有权
    包含分子开关的寡核苷酸

    公开(公告)号:US08679789B2

    公开(公告)日:2014-03-25

    申请号:US10837530

    申请日:2004-04-30

    IPC分类号: C12P19/34

    摘要: This invention relates to oligonucleotides comprising a molecular switch which may exist in an “open” or “closed” position. The molecular switch portion of the probe is particularly sensitive to the identity of sequences complementary to the molecular switch. Oligonucleotides containing a molecular switch are applicable to all kinds of hybridization processes. Due to the sensitivity of the switch domain of the oligonucleotide, probes containing a molecular switch are particularly useful in the identification of single point mismatches. More specifically, a portion, but not all, of the oligonucleotide becomes unbound from a mismatched target. The invention further relates to methods of using said oligonucleotides for research reagents, and clinical diagnostics. An exemplary oligonucleotide comprises a first hybridizable domain, a second bridging block domain, and a third binding domain.

    摘要翻译: 本发明涉及包含分子开关的寡核苷酸,分子开关可以存在于“开放”或“闭合”位置。 探针的分子开关部分对与分子开关互补的序列的身份特别敏感。 含有分子开关的寡核苷酸适用于各种杂交过程。 由于寡核苷酸的开关结构域的灵敏度,含有分子开关的探针在识别单点错配中特别有用。 更具体地,寡核苷酸的一部分但不是全部从失配的靶变得不结合。 本发明还涉及将所述寡核苷酸用于研究试剂和临床诊断的方法。 示例性寡核苷酸包含第一可杂交结构域,第二桥连嵌段结构域和第三结合结构域。

    LIPID DELIVERY FORMULATIONS
    10.
    发明申请
    LIPID DELIVERY FORMULATIONS 有权
    LIPID交付配方

    公开(公告)号:US20130225663A1

    公开(公告)日:2013-08-29

    申请号:US13595360

    申请日:2012-08-27

    申请人: Bob D. Brown

    发明人: Bob D. Brown

    IPC分类号: A61K47/28 A61K47/24 A61K47/18

    摘要: The invention provides formulations that contain an immunogenic or immunostimulatory cargo, delivery moiety and/or lipid, and a lipid that functions to reduce or prevent induction in a subject of an immune response which would otherwise occur when the immunogenic or immunostimulatory cargo, delivery moiety and/or lipid is administered to a subject as a component of an appropriate control formulation lacking the immune response reducing lipid. Specific immune response reducing lipids and uses thereof are further provided.

    摘要翻译: 本发明提供含有免疫原性或免疫刺激性货物,递送部分和/或脂质的制剂,以及用于减少或预防免疫应答受试者诱导的脂质,否则当免疫原性或免疫刺激性货物,递送部分和 /或脂质作为缺乏免疫应答降低脂质的适当对照制剂的组分施用于受试者。 进一步提供减少脂质的特异性免疫应答及其用途。